<!DOCTYPE html><html class="turbolinks-progress-bar"><head><meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"><meta content="fdhmwDBTGwNPe0lKcJVly7AToLfZYvJ-mtjFAPTMZGs" name="google-site-verification"><meta content="296E0FF6379AE64A0D18C39BB40ECD6E" name="msvalidate.01"><title>Pharmaco-metabolomics | DrugBank Online</title><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-57x57-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-60x60-precomposed.png" sizes="60x60"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-72x72-precomposed.png" sizes="72x72"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-76x76-precomposed.png" sizes="76x76"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-114x114-precomposed.png" sizes="114x114"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-120x120-precomposed.png" sizes="120x120"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-144x144-precomposed.png" sizes="144x144"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-152x152-precomposed.png" sizes="152x152"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-180x180-precomposed.png" sizes="180x180"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon.png" sizes="57x57"><link rel="icon" type="image/png" href="/favicons/favicon-96x96.png" sizes="96x96"><link rel="icon" type="image/png" href="/favicons/favicon-32x32.png" sizes="32x32"><link rel="icon" type="image/png" href="/favicons/favicon-16x16.png" sizes="16x16"><link rel="icon" type="image/png" href="/favicons/favicon.png" sizes="16x16"><link rel="shortcut icon" type="image/x-icon" href="/favicons/favicon.ico"><meta content="#da532c" name="msapplication-TileColor"><meta content="/favicons/mstile-144x144.png" name="msapplication-TileImage"><meta content="#ffffff" name="theme-color"><meta content="DrugBank" name="application-name"><link as="font" crossorigin="" href="/assets/GemeliWeb-Regular-9ccb07b090f3aef673e3b29ba66e2e685ccf3d438e550624d9739f1bd5164cb2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Bold-f344ff98a063f8cb6ac490b132bda4035ecc8984358dfa8d9bd8621fa38744e2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Light-8227f53ee1957ae57cc0c81d1cfecb59238e3fd9d32b1e792432e1f8c81784a1.woff2" rel="preload" type="font/woff2"><link as="style" data-turbolinks-track="true" href="/assets/public_preload-ec9281ddba7498de9953c0f69a4b77e3e6b7f8f23fe47e1c347b028af890fc0e.css" media="all" onload="this.onload=null;this.rel='stylesheet'" rel="stylesheet"><noscript>&lt;link href="/assets/public_preload-ec9281ddba7498de9953c0f69a4b77e3e6b7f8f23fe47e1c347b028af890fc0e.css" media="all" rel="stylesheet" /&gt;</noscript><link rel="stylesheet" media="all" href="/assets/public-720199d14ecb75df792c22a0b89a1e5817dab39ae1fda73ea0da1c4d7f67510b.css" data-turbolinks-track="true"><script type="text/javascript" async="" src="https://www.googleadservices.com/pagead/conversion_async.js"></script><script type="text/javascript" async="" src="https://snap.licdn.com/li.lms-analytics/insight.min.js"></script><script async="" src="https://d.clarity.ms/s/0.6.27/clarity.js"></script><script src="https://js.hsadspixel.net/fb.js" type="text/javascript" id="hs-ads-pixel-2224137" data-ads-portal-id="2224137" data-ads-env="prod" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script src="https://js.hs-banner.com/2224137.js" type="text/javascript" id="cookieBanner-2224137" data-cookieconsent="ignore" data-hs-ignore="true" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script src="https://js.hs-analytics.net/analytics/1636199100000/2224137.js" type="text/javascript" id="hs-analytics"></script><script async="" src="//www.google-analytics.com/analytics.js"></script><script async="" src="https://www.clarity.ms/tag/5600r08mxy"></script><script src="/assets/public-27f932f135aadc4b526264005f1d5e85b32bfbdf9c790701e4b7be02cb9db204.js" media="all" data-turbolinks-track="true" defer="defer"></script><script>(function(c,l,a,r,i,t,y){
    c[a]=c[a]||function(){(c[a].q=c[a].q||[]).push(arguments)};
    t=l.createElement(r);t.async=1;t.src="https://www.clarity.ms/tag/"+i;
    y=l.getElementsByTagName(r)[0];y.parentNode.insertBefore(t,y);
})(window, document, "clarity", "script", "5600r08mxy");</script><meta name="csrf-param" content="authenticity_token">
<meta name="csrf-token" content="k0jTFKs2mscGk3kAZZqq3RwMjqvKc7EwBVJ7y59G+2oVMA5zX0Kmq0RPAqk75D1t2B0mSvuobgChXZULDpuB6w=="><style>html.turbolinks-progress-bar::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  z-index: 2000;
  background-color: #0076ff;
  height: 3px;
  opacity: 0.99;
  width: 0%;
  transition: width 300ms ease-out, opacity 150ms ease-in;
  transform: translate3d(0,0,0);
}</style><script async="" src="https://www.googletagmanager.com/gtag/js?id=AW-704543816"></script><script src="https://googleads.g.doubleclick.net/pagead/viewthroughconversion/704543816/?random=1636199138282&amp;cv=9&amp;fst=1636199138282&amp;num=1&amp;bg=ffffff&amp;guid=ON&amp;resp=GooglemKTybQhCsO&amp;u_h=720&amp;u_w=1280&amp;u_ah=720&amp;u_aw=1280&amp;u_cd=24&amp;u_his=100&amp;u_tz=180&amp;u_java=true&amp;u_nplug=0&amp;u_nmime=0&amp;gtm=2oab31&amp;sendb=1&amp;ig=1&amp;data=event%3Dgtag.config&amp;frm=0&amp;url=https%3A%2F%2Fgo.drugbank.com%2Fpharmaco%2Fmetabolomics%3Fpage%3D114&amp;tiba=Pharmaco-metabolomics%20%7C%20DrugBank%20Online&amp;hn=www.googleadservices.com&amp;async=1&amp;rfmt=3&amp;fmt=4"></script></head><body class="pharmaco-metabolite-regulations-c index-a has-banner"><header><nav class="navbar fixed-top navbar-expand-custom navbar-light" id="main-nav" style="background-color: #ff00b8;"><a class="navbar-brand" href="/"><img style="width: 178px; height: 20px;" src="/assets/logo-white-dd185d748ee0164b8ee8f88df29235cd8cfc7936a3c974589262c667e9294219.svg" alt="Logo white"><div class="online">Online</div></a><button aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler navbar-toggler-right" data-target="#navbar" data-toggle="collapse" type="button"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbar"><ul class="navbar-nav ml-auto"><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Browse</a><div class="dropdown-menu"><a class="dropdown-item" href="/drugs"><div class="icon-circle drugbank-icon icon-drugs"><svg class="icon" role="img" title="drugs">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#drugs"></use>
</svg>
</div> Drugs</a><a class="dropdown-item" href="/drugs/starred"><div class="icon-circle drugbank-icon icon-star"><svg class="icon" role="img" title="star">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#star"></use>
</svg>
</div> Starred Drugs</a><a class="dropdown-item" href="/categories"><div class="icon-circle drugbank-icon icon-categories"><svg class="icon" role="img" title="categories">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#categories"></use>
</svg>
</div> Categories</a><a class="dropdown-item" href="/pathways"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#pathways"></use>
</svg>
</div> Pathways</a><a class="dropdown-item" href="/reactions"><div class="icon-circle drugbank-icon icon-reactions"><svg class="icon" role="img" title="reactions">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#reactions"></use>
</svg>
</div> Drug Reactions</a><a class="dropdown-item" href="/classyfication"><div class="icon-circle drugbank-icon icon-classifications"><svg class="icon" role="img" title="classifications">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#classifications"></use>
</svg>
</div> Drug Classification</a><a class="dropdown-item" href="/targets"><div class="icon-circle drugbank-icon icon-targets"><svg class="icon" role="img" title="targets">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#targets"></use>
</svg>
</div> Drug Targets</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/pharmaco/genomics"><div class="icon-circle drugbank-icon icon-geno-browse"><svg class="icon" role="img" title="geno-browse">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#geno-browse"></use>
</svg>
</div> Pharmaco-genomics</a><a class="dropdown-item" href="/pharmaco/metabolomics"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#chemquery"></use>
</svg>
</div> Pharmaco-metabolomics</a><a class="dropdown-item" href="/pharmaco/transcriptomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Pharmaco-transcriptomics</a><a class="dropdown-item" href="/pharmaco/proteomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Pharmaco-proteomics</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">COVID-19</a><div class="dropdown-menu"><a class="dropdown-item" href="/covid-19"><div class="icon-circle drugbank-icon icon-covid-overview"><svg class="icon" role="img" title="covid-overview">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#covid-overview"></use>
</svg>
</div> Overview</a><a class="dropdown-item" href="/covid-19-vaccination"><div class="icon-circle drugbank-icon icon-covid-vaccination"><svg class="icon" role="img" title="covid-vaccination">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#covid-vaccination"></use>
</svg>
</div> Vaccine Side Effects</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Search</a><div class="dropdown-menu"><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/structure"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#chemquery"></use>
</svg>
</div> Chemical Structure</a><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/mass"><div class="icon-circle drugbank-icon icon-molecular-weight"><svg class="icon" role="img" title="molecular-weight">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#molecular-weight"></use>
</svg>
</div> Molecular Weight</a><a class="dropdown-item" href="/drug-interaction-checker"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Drug &amp; Food Interactions</a><a class="dropdown-item" data-no-turbolink="true" href="/structures/search/bonds/sequence"><div class="icon-circle drugbank-icon icon-sequence"><svg class="icon" role="img" title="sequence">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#sequence"></use>
</svg>
</div> Target Sequences</a><a class="dropdown-item" data-no-turbolink="true" href="/pharmaco/search"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#pathways"></use>
</svg>
</div> Pharmaco-omics</a><a class="dropdown-item" href="/unearth/advanced/drugs"><div class="icon-circle drugbank-icon icon-advanced"><svg class="icon" role="img" title="advanced">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#advanced"></use>
</svg>
</div> Advanced Search</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/spectra/ms/search"><div class="icon-circle drugbank-icon icon-ms"><svg class="icon" role="img" title="ms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#ms"></use>
</svg>
</div> MS Search</a><a class="dropdown-item" href="/spectra/ms_ms/search"><div class="icon-circle drugbank-icon icon-msms"><svg class="icon" role="img" title="msms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#msms"></use>
</svg>
</div> MS/MS Search</a><a class="dropdown-item" href="/spectra/c_ms/search"><div class="icon-circle drugbank-icon icon-gcms"><svg class="icon" role="img" title="gcms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#gcms"></use>
</svg>
</div> GC/MS Search</a><a class="dropdown-item" href="/spectra/nmr_one_d/search"><div class="icon-circle drugbank-icon icon-nmr-1d"><svg class="icon" role="img" title="nmr-1d">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#nmr-1d"></use>
</svg>
</div> 1D NMR Search</a><a class="dropdown-item" href="/spectra/nmr_two_d/search"><div class="icon-circle drugbank-icon icon-nmr-2d"><svg class="icon" role="img" title="nmr-2d">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#nmr-2d"></use>
</svg>
</div> 2D NMR Search</a></div></li><li class="nav-item"><a class="nav-link" href="/drug-interaction-checker">Interaction Checker</a></li><li class="nav-item"><a class="nav-link" href="/releases/latest">Downloads</a></li><li class="nav-item dropdown" role="presentation"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Solutions</a><div class="dropdown-menu"><div class="link-header dropdown-item">Products</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/clinical"><div class="icon-pink product-icon drugbank-icon icon-clinical"><svg class="icon" role="img" title="clinical"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#clinical"> </use></svg></div> Clinical Drug API</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/scientific"><div class="icon-pink product-icon drugbank-icon icon-scientific"><svg class="icon" role="img" title="scientific"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#scientific"> </use></svg></div> Scientific Drug Data</a><div class="link-header dropdown-item">Industries</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/drug_discovery">Drug Discovery</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/drug_repurposing">Drug Repurposing</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/precision_medicine">Precision Medicine</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/machine_learning">Machine Learning</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/telehealth">Telehealth</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/electronic_medical_records">Electronic Medical Records</a><div class="link-header dropdown-item">Resources</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/downloads">White Papers</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">About</a><div class="dropdown-menu right-menu"><div class="col-menu"><div class="menu-col"><div class="link-header dropdown-item"><a target="_blank" href="https://dev.drugbank.com/guides/index"><div class=" drugbank-icon icon-help_center"><svg class="icon" role="img" title="help_center"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#help_center"> </use></svg></div> Help Center</a></div><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/citing"><div class="icon-circle drugbank-icon icon-citing"><svg class="icon" role="img" title="citing">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#citing"></use>
</svg>
</div> Citing DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/faqs"><div class="icon-circle drugbank-icon icon-faq"><svg class="icon" role="img" title="faq">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#faq"></use>
</svg>
</div> DrugBank Online FAQs</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/searching"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> Searching DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/other_databases"><div class="icon-circle drugbank-icon icon-database"><svg class="icon" role="img" title="database">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#database"></use>
</svg>
</div> Other Databases</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/fields/drugs"><div class="icon-circle drugbank-icon icon-data-sources"><svg class="icon" role="img" title="data-sources">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#data-sources"></use>
</svg>
</div> Data Sources</a></div><div class="menu-col"><div class="link-header dropdown-item"><div class=" drugbank-icon icon-quick_link"><svg class="icon" role="img" title="quick_link"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#quick_link"> </use></svg></div> About</div><a class="dropdown-item" href="/about"><div class="icon-circle drugbank-icon icon-drugbank"><svg class="icon" role="img" title="drugbank">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#drugbank"></use>
</svg>
</div> About DrugBank Online</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/publications"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> DrugBank in Research</a><a class="dropdown-item" href="/stats"><div class="icon-circle drugbank-icon icon-statistics"><svg class="icon" role="img" title="statistics">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#statistics"></use>
</svg>
</div> Statistics</a><a class="dropdown-item" target="_blank" rel="noopener" href="https://blog.drugbank.com/"><div class="icon-circle drugbank-icon icon-news"><svg class="icon" role="img" title="news">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#news"></use>
</svg>
</div> Blog</a><a target="_blank" rel="noopener" class="dropdown-item" href="http://www.wishartlab.com"><div class="icon-circle drugbank-icon icon-wishart"><svg class="icon" role="img" title="wishart">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#wishart"></use>
</svg>
</div> Wishart Research Group</a><a class="dropdown-item" href="/contact"><div class="small-icon icon-circle drugbank-icon icon-paper-plane"><svg class="icon" role="img" title="paper-plane">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#paper-plane"></use>
</svg>
</div> Contact Us</a></div></div></div></li></ul></div></nav><nav class="navbar fixed-top navbar-expand search-bar justify-content-center justify-content-sm-end d-flex"><div class="form-container"><form class="form-inline" action="/unearth/q" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓"><div class="search-group d-none d-sm-block" style="margin-right: 0.5rem;"><select name="searcher" id="searcher" class="form-control input-md"><option value="drugs">Drugs</option>
<option value="bio_entities">Targets</option>
<option value="pathways">Pathways</option>
<option value="indications">Indications</option></select> <div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> </div><div class="search-group"><input type="text" name="query" id="query" class="search-query"> <div class="drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> </div></form></div><div class="mini-banner banner-holder"><a target="_blank" href="https://app.livestorm.co/drugbank/improve-and-accelerate-early-stage-drug-discoveries"><div class="banner-text"><span class="mr-3">New Webinar + Q&amp;A: Learn how DrugBank improves and accelerates early-stage drug discoveries</span><span class="banner-link"><span>Register Now</span><div class="icon-circle drugbank-icon icon-arrow-right"><svg class="icon" role="img" title="arrow-right">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-right"></use>
</svg>
</div></span></div></a><div class="close-banner"><div class="drugbank-icon icon-cross"><svg class="icon" role="img" title="cross">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#cross"></use>
</svg>
</div></div></div></nav></header><main role="main"><div class="content-container"><div class="content-header d-sm-flex align-items-center"><h1 class="align-self-center mr-auto">Pharmaco-metabolomics<small>Metabolite changes due to the metabolism of pharmaceutical compounds</small></h1><div class="page-actions ml-auto justify-content-sm-end mt-2 mt-sm-0"><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/genomics">Pharmaco-genomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1 disabled" href="/pharmaco/metabolomics">Pharmaco-metabolomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/transcriptomics">Pharmaco-transcriptomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/proteomics">Pharmaco-proteomics</a><a data-no-turbolink="true" class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/search">Search</a></div></div><form class="metabolite_regulation_search" id="metabolite_regulation_search" action="/pharmaco/metabolomics" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓"><div class="container-fluid"><div class="filter-bar row justify-content-start d-flex flex-wrap flex-column flex-sm-row"><div class="advanced-toggle d-flex d-sm-none justify-content-between align-items-center"><h3>Advanced Filter</h3><div class="toggle"><div class="drugbank-icon icon-add"><svg class="icon" role="img" title="add">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#add"></use>
</svg>
</div><div class="drugbank-icon icon-subtract"><svg class="icon" role="img" title="subtract">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#subtract"></use>
</svg>
</div></div></div><div class="advanced-selector justify-content-start d-sm-flex flex-wrap flex-column flex-sm-row"><div class="group-selector d-sm-block"><h3>Filter by Group</h3><input value="or" type="hidden" name="q[g[0]][m]" id="q_g_0__m"><div class="form-check"><label class="button-control button-check-box" for="approved"><input name="q[g[0]][drug_approved_true]" type="hidden" value="all"><input class="button-control-input" id="approved" type="checkbox" value="1" name="q[g[0]][drug_approved_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Approved</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="nutraceutical"><input name="q[g[0]][drug_nutraceutical_true]" type="hidden" value="all"><input class="button-control-input" id="nutraceutical" type="checkbox" value="1" name="q[g[0]][drug_nutraceutical_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Nutraceutical</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="illicit"><input name="q[g[0]][drug_illicit_true]" type="hidden" value="all"><input class="button-control-input" id="illicit" type="checkbox" value="1" name="q[g[0]][drug_illicit_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Illicit</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="investigational"><input name="q[g[0]][drug_investigational_true]" type="hidden" value="all"><input class="button-control-input" id="investigational" type="checkbox" value="1" name="q[g[0]][drug_investigational_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Investigational</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="withdrawn"><input name="q[g[0]][drug_withdrawn_true]" type="hidden" value="all"><input class="button-control-input" id="withdrawn" type="checkbox" value="1" name="q[g[0]][drug_withdrawn_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Withdrawn</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="experimental"><input name="q[g[0]][drug_experimental_true]" type="hidden" value="all"><input class="button-control-input" id="experimental" type="checkbox" value="1" name="q[g[0]][drug_experimental_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Experimental</span></span></label></div></div><div class="availability-selector d-sm-block"><h3>Filter by Market Availability</h3><input value="or" type="hidden" name="q[g[1]][m]" id="q_g_1__m"><div class="form-check"><label class="button-control button-check-box" for="us"><input name="q[g[1]][drug_available_in_us_true]" type="hidden" value="all"><input class="button-control-input" id="us" type="checkbox" value="1" name="q[g[1]][drug_available_in_us_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">U.S.</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="ca"><input name="q[g[1]][drug_available_in_ca_true]" type="hidden" value="all"><input class="button-control-input" id="ca" type="checkbox" value="1" name="q[g[1]][drug_available_in_ca_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Canada</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="eu"><input name="q[g[1]][drug_available_in_eu_true]" type="hidden" value="all"><input class="button-control-input" id="eu" type="checkbox" value="1" name="q[g[1]][drug_available_in_eu_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">E.U.</span></span></label></div></div><div class="submit-filter ml-sm-auto pb-sm-0 justify-content-end d-sm-flex pt-2 align-items-end text-center"><div class="submit-buttons mt-2"><a class="btn btn-drugbank-secondary btn-sm mr-2" href="https://go.drugbank.com/pharmaco/metabolomics">Clear</a><input type="submit" name="commit" value="Apply Filter" class="btn btn-drugbank-primary btn-sm" data-disable-with="Apply Filter"></div></div></div></div></div><div class="index-content"><div class="pagination-holder"><div class="page_info">Displaying entries <b>2826&nbsp;-&nbsp;2850</b> of <b>3084</b> in total</div><nav><ul class="pagination pagination-sm"><li class="page-item first"><a class="page-link" href="/pharmaco/metabolomics">«</a></li><li class="page-item previous"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=113">‹</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=110">110</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=111">111</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=112">112</a></li><li class="page-item"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=113">113</a></li><li class="page-item active"><a remote="false" class="page-link">114</a></li><li class="page-item"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=115">115</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=116">116</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=117">117</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=118">118</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item next"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=115">›</a></li><li class="page-item last"><a class="page-link" href="/pharmaco/metabolomics?page=124">»</a></li></ul></nav></div><table class="table-metabolite-regulations table table-bordered"><thead><tr><th>Drug</th><th>Drug Groups</th><th>Metabolite</th><th>Change</th><th>Description</th><th>Reference</th></tr><tr class="table-search-row"><th><input class=" form-control input-md input-tbl-search" type="text" name="q[drug_precise_names_name_cont]" id="q_drug_precise_names_name_cont"></th><th></th><th><input class=" form-control input-md input-tbl-search" type="text" name="q[metabolite_cont]" id="q_metabolite_cont"></th><th><select class=" form-control input-sm input-tbl-search select2-standard" name="q[change_eq]" id="q_change_eq"><option value=""></option>
<option value="increased">increased</option>
<option value="decreased">decreased</option></select></th><th></th><th class="table-search-submit"><div class="btn-group"><button name="button" type="submit" class="table-search-submit btn btn-sm btn-light"><div class="drugbank-icon icon-search-big"><svg class="icon" role="img" title="search-big">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search-big"></use>
</svg>
</div></button> <a id="table-search-reset" class="btn btn-light btn-sm" href="/pharmaco/metabolomics">Clear</a></div></th></tr></thead><tbody><tr><td><a href="/drugs/DB00284">Acarbose</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Acarbose <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26285" data-original-title="Malaguarnera M, Giugno I, Ruello P, Rizzo M, Motta M, Mazzoleni G: Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias. Br J Clin Pharmacol. 1999 Oct;48(4):605-9.">A26285</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26286" data-original-title="Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, Fucker K: Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care. 1991 Aug;14(8):732-7.">A26286</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24920" data-original-title="Leonhardt W, Hanefeld M, Fischer S, Schulze J, Spengler M: Beneficial effects on serum lipids in noninsulin dependent diabetics by acarbose treatment. Arzneimittelforschung. 1991 Jul;41(7):735-8.">A24920</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25757" data-original-title="Zhou J, Deng Z, Lu J, Li H, Zhang X, Peng Y, Mo Y, Bao Y, Jia W: Differential therapeutic effects of nateglinide and acarbose on fasting and postprandial lipid profiles: a randomized trial. Diabetes Technol Ther. 2015 Apr;17(4):229-34. doi: 10.1089/dia.2014.0299.">A25757</a></li></ul></td></tr><tr><td><a href="/drugs/DB00584">Enalapril</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Vet Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00562">Creatinine</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Enalapril <em>increases</em> the level of <em>Creatinine</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26287" data-original-title="Ljungman S, Kjekshus J, Swedberg K: Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). Am J Cardiol. 1992 Aug 15;70(4):479-87.">A26287</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26288" data-original-title="Sevela K, Zicha J, Pokorna V: [Effect of ACE-inhibitors on changes in creatinine in the blood-- introduction]. Vnitr Lek. 1999 Nov;45(11):650-4.">A26288</a></li></ul></td></tr><tr><td><a href="/drugs/DB00973">Ezetimibe</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>LDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Ezetimibe <em>decreases</em> the level of <em>LDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26289" data-original-title="Zafrir B, Jain M: Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. Cardiovasc Drugs Ther. 2014 Aug;28(4):361-77. doi: 10.1007/s10557-014-6534-9.">A26289</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25592" data-original-title="Hiramitsu S, Ishiguro Y, Matsuyama H, Yamada K, Kato K, Noba M, Uemura A, Yoshida S, Matsubara Y, Kani A, Hasegawa K, Hishida H, Ozaki Y: The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. J Atheroscler Thromb. 2010 Feb;17(1):106-14. Epub 2010 Jan 14.">A25592</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A11250" data-original-title="Wang J, Williams CM, Hegele RA: Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe. Clin Genet. 2005 Feb;67(2):175-7.">A11250</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26290" data-original-title="McCarty MF: An ezetimibe-policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects. Med Hypotheses. 2005;64(3):636-45.">A26290</a></li></ul></td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Non-HDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Colesevelam <em>decreases</em> the level of <em>Non-HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25850" data-original-title="Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR: Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes Care. 2008 Aug;31(8):1479-84. doi: 10.2337/dc08-0283. Epub 2008 May 5.">A25850</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26058" data-original-title="Handelsman Y, Goldberg RB, Garvey WT, Fonseca VA, Rosenstock J, Jones MR, Lai YL, Jin X, Misir S, Nagendran S, Abby SL: Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study. Endocr Pract. 2010 Jul-Aug;16(4):617-28. doi: 10.4158/EP10129.OR.">A26058</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25890" data-original-title="Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR: Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes. Postgrad Med. 2012 Jul;124(4):14-20. doi: 10.3810/pgm.2012.07.2564.">A25890</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25643" data-original-title="Vega GL, Dunn FL, Grundy SM: Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome. Am J Cardiol. 2011 Oct 15;108(8):1129-35. doi: 10.1016/j.amjcard.2011.06.011. Epub 2011 Aug 1.">A25643</a></li></ul></td></tr><tr><td><a href="/drugs/DB00169">Cholecalciferol</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Nutraceutical</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB01438">25-hydroxyvitamin D</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Cholecalciferol <em>increases</em> the level of <em>25-hydroxyvitamin D</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25758" data-original-title="Curiel-Lewandrowski C, Tang JY, Einspahr JG, Bermudez Y, Hsu CH, Rezaee M, Lee AH, Tangrea J, Parnes HL, Alberts DS, Chow HH: Pilot study on the bioactivity of vitamin d in the skin after oral supplementation. Cancer Prev Res (Phila). 2015 Jun;8(6):563-9. doi: 10.1158/1940-6207.CAPR-14-0280. Epub 2015 Apr 2.">A25758</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25661" data-original-title="Zhang H, Huang QR, Gu JM, Hu WW, Liu YJ, Hu YQ, Zhang ZL: Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency. Acta Pharmacol Sin. 2012 Apr;33(4):490-5. doi: 10.1038/aps.2011.172. Epub 2012 Mar 12.">A25661</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26291" data-original-title="Cupisti A, Vigo V, Baronti ME, D'Alessandro C, Ghiadoni L, Egidi MF: Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report. Int J Nephrol Renovasc Dis. 2015 Nov 19;8:151-7. doi: 10.2147/IJNRD.S90968. eCollection 2015.">A26291</a></li></ul></td></tr><tr><td><a href="/drugs/DB00627">Niacin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span> <span class="badge badge-secondary badge-pill">Nutraceutical</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Niacin <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26292" data-original-title="Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M: Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009  Nov 15.">A26292</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25397" data-original-title="Talpur R, Ward S, Apisarnthanarax N, Breuer-Mcham J, Duvic M: Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2002 Nov;47(5):672-84.">A25397</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26276" data-original-title="Lilley JS, Linton MF, Fazio S: Oral retinoids and plasma lipids. Dermatol Ther. 2013 Sep-Oct;26(5):404-10. doi: 10.1111/dth.12085.">A26276</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25844" data-original-title="Pradhan B, Neopane A, Karki S, Karki DB: Effectiveness of nicotinic acid and bezafibrate alone and in combination for reducing serum triglyceride level. Kathmandu Univ Med J (KUMJ). 2005 Oct-Dec;3(4):411-4.">A25844</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24963" data-original-title="Garg A, Grundy SM: Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA. 1990 Aug 8;264(6):723-6.">A24963</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25891" data-original-title="Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB, Sheps DS, Brinton EA: Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. JAMA. 2000 Sep 13;284(10):1263-70.">A25891</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25892" data-original-title="Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP: Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med. 2002 Jul 22;162(14):1568-76.">A25892</a></li></ul></td></tr><tr><td><a href="/drugs/DB00437">Allopurinol</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00289">Uric acid</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Allopurinol <em>decreases</em> the level of <em>Uric acid</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25627" data-original-title="Wei L, Mackenzie IS, Chen Y, Struthers AD, MacDonald TM: Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol. 2011 Apr;71(4):600-7. doi: 10.1111/j.1365-2125.2010.03887.x.">A25627</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A664" data-original-title="Pacher P, Nivorozhkin A, Szabo C: Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006 Mar;58(1):87-114.">A664</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26293" data-original-title="Inokuchi T, Ka T, Yamamoto A, Takahashi S, Tsutsumi Z, Moriwaki Y, Yamamoto T: Effects of allopurinol on beer-induced increases in plasma concentrations of purine bases and uridine. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):601-3. doi: 10.1080/15257770802138392.">A26293</a></li></ul></td></tr><tr><td><a href="/drugs/DB00175">Pravastatin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB01170">Lathosterol</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Pravastatin <em>decreases</em> the level of <em>Lathosterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24929" data-original-title="Elmberger PG, Kalen A, Lund E, Reihner E, Eriksson M, Berglund L, Angelin B, Dallner G: Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia. J Lipid Res. 1991 Jun;32(6):935-40.">A24929</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25728" data-original-title="Altmaier E, Fobo G, Heier M, Thorand B, Meisinger C, Romisch-Margl W, Waldenberger M, Gieger C, Illig T, Adamski J, Suhre K, Kastenmuller G: Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism. Eur J Epidemiol. 2014 May;29(5):325-36. doi: 10.1007/s10654-014-9910-7. Epub 2014 May 10.">A25728</a></li></ul></td></tr><tr><td><a href="/drugs/DB00966">Telmisartan</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Telmisartan <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26294" data-original-title="Aoki A, Ogawa T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Nitta K: Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients. Heart Vessels. 2010 May;25(3):195-202. doi: 10.1007/s00380-009-1186-6. Epub 2010  May 29.">A26294</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25604" data-original-title="Wago T, Yoshimoto T, Akaza I, Tsuchiya K, Izumiyama H, Doi M, Hirata Y: Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan. Hypertens Res. 2010 Aug;33(8):796-801. doi: 10.1038/hr.2010.107. Epub 2010 Jun 17.">A25604</a></li></ul></td></tr><tr><td><a href="/drugs/DB01393">Bezafibrate</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Bezafibrate <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25869" data-original-title="Zimetbaum P, Frishman WH, Kahn S: Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol. 1991 Jan;31(1):25-37.">A25869</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26295" data-original-title="Rustemeijer C, Schouten JA, Voerman HJ, Beynen AC, Donker AJ, Heine RJ: Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus? Clin Sci (Lond). 2001 Jul;101(1):29-35.">A26295</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26033" data-original-title="Kobayashi J, Takahashi K, Tashiro J, Shirai K, Saito Y, Yoshida S, Hashimoto H, Fukamachi I, Niihara K, Sasaki N: Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia. Arzneimittelforschung. 1994 Feb;44(2):145-8.">A26033</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26296" data-original-title="de Man FH, de Beer F, van der Laarse A, Jansen H, Leuven JA, Souverijn JH, Vroom TF, Schoormans SC, Fruchart JC, Havekes LM, Smelt AH: The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding. Atherosclerosis. 2000 Dec;153(2):363-71.">A26296</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25295" data-original-title="Durrington PN, Mackness MI, Bhatnagar D, Julier K, Prais H, Arrol S, Morgan J, Wood GN: Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia. Atherosclerosis. 1998 May;138(1):217-25.">A25295</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24944" data-original-title="Nakandakare E, Garcia RC, Rocha JC, Sperotto G, Oliveira HC, Quintao EC: Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins. Atherosclerosis. 1990 Dec;85(2-3):211-7.">A24944</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25655" data-original-title="McCullough PA, Ahmed AB, Zughaib MT, Glanz ED, Di Loreto MJ: Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. Rev Cardiovasc Med. 2011;12(4):173-85. doi: 10.3909/ricm0619.">A25655</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25182" data-original-title="Hidalgo L, Zambrana JL, Blanco-Molina A, Lopez-Granados A, Concha M, Casares J, Jimenez-Perez J, Lopez-Miranda J, Perez-Jimenez F: Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation. J Heart Lung Transplant. 1995 May-Jun;14(3):461-7.">A25182</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li></ul></td></tr><tr><td><a href="/drugs/DB00636">Clofibrate</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00054">Bilirubin</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Clofibrate <em>decreases</em> the level of <em>Bilirubin</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24845" data-original-title="Dujovne CA, Azarnoff DL, Huffman DH, Pentikainen P, Hurwitz A, Shoeman DW: One-year trials with halofenate, clofibrate, and placebo. Clin Pharmacol Ther. 1976 Mar;19(3):352-9.">A24845</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25142" data-original-title="Lageder H: [Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia]. Wien Klin Wochenschr. 1980 Feb 1;92(3):95-101.">A25142</a></li></ul></td></tr><tr><td><a href="/drugs/DB00776">Oxcarbazepine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00588">Sodium</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Oxcarbazepine <em>decreases</em> the level of <em>Sodium</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26297" data-original-title="Pendlebury SC, Moses DK, Eadie MJ: Hyponatraemia during oxcarbazepine therapy. Hum Toxicol. 1989 Sep;8(5):337-44.">A26297</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25549" data-original-title="Liamis G, Milionis H, Elisaf M: A review of drug-induced hyponatremia. Am J Kidney Dis. 2008 Jul;52(1):144-53. doi: 10.1053/j.ajkd.2008.03.004. Epub 2008 May 12.">A25549</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25367" data-original-title="Isojarvi JI, Huuskonen UE, Pakarinen AJ, Vuolteenaho O, Myllyla VV: The regulation of serum sodium after replacing carbamazepine with oxcarbazepine. Epilepsia. 2001 Jun;42(6):741-5.">A25367</a></li></ul><ul class="list-unstyled table-list"><li><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45a6d619-9198-45c3-b9fa-1b52325366d3">DailyMed</a></li></ul></td></tr><tr><td><a href="/drugs/DB00776">Oxcarbazepine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00588">Sodium</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Oxcarbazepine <em>decreases</em> the level of <em>Sodium</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25549" data-original-title="Liamis G, Milionis H, Elisaf M: A review of drug-induced hyponatremia. Am J Kidney Dis. 2008 Jul;52(1):144-53. doi: 10.1053/j.ajkd.2008.03.004. Epub 2008 May 12.">A25549</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25367" data-original-title="Isojarvi JI, Huuskonen UE, Pakarinen AJ, Vuolteenaho O, Myllyla VV: The regulation of serum sodium after replacing carbamazepine with oxcarbazepine. Epilepsia. 2001 Jun;42(6):741-5.">A25367</a></li></ul></td></tr><tr><td><a href="/drugs/DB00214">Torasemide</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00289">Uric acid</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Torasemide <em>increases</em> the level of <em>Uric acid</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26238" data-original-title="Friedel HA, Buckley MM: Torasemide. A review of its pharmacological properties and therapeutic potential. Drugs. 1991 Jan;41(1):81-103.">A26238</a></li></ul></td></tr><tr><td><a href="/drugs/DB01039">Fenofibrate</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>VLDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Fenofibrate <em>decreases</em> the level of <em>VLDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24942" data-original-title="Klosiewicz-Latoszek L, Szostak WB: Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. Eur J Clin Pharmacol. 1991;40(1):33-41.">A24942</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25421" data-original-title="Bilz S, Wagner S, Schmitz M, Bedynek A, Keller U, Demant T: Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia. J Lipid Res. 2004 Jan;45(1):174-85. Epub 2003 Oct 1.">A25421</a></li></ul></td></tr><tr><td><a href="/drugs/DB00871">Terbutaline</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00586">Potassium</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Terbutaline <em>decreases</em> the level of <em>Potassium</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A16842" data-original-title="Nuttall SL, Routledge HC, Kendall MJ: A comparison of the beta1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther. 2003 Jun;28(3):179-86.">A16842</a></li></ul></td></tr><tr><td><a href="/drugs/DB01235">Levodopa</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00742">Homocysteine</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Levodopa <em>increases</em> the level of <em>Homocysteine</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26298" data-original-title="Valkovic P, Benetin J, Blazicek P, Valkovicova L, Gmitterova K, Kukumberg P: Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients. Parkinsonism Relat Disord. 2005 Jun;11(4):253-6. Epub 2005 Apr 20.">A26298</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26299" data-original-title="Zesiewicz TA, Wecker L, Sullivan KL, Merlin LR, Hauser RA: The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status. Clin Neuropharmacol. 2006 May-Jun;29(3):106-11.">A26299</a></li></ul></td></tr><tr><td><a href="/drugs/DB00343">Diltiazem</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00190">Lactate</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Diltiazem <em>increases</em> the level of <em>Lactate</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26253" data-original-title="Bouckaert J, Lefebvre R, Pannier JL: Effects of diltiazem and atenolol on exercise performance in man. J Sports Med Phys Fitness. 1989 Sep;29(3):240-4.">A26253</a></li></ul></td></tr><tr><td><a href="/drugs/DB01098">Rosuvastatin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Rosuvastatin <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26300" data-original-title="Verges B, Florentin E, Baillot-Rudoni S, Monier S, Petit JM, Rageot D, Gambert P, Duvillard L: Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes. Diabetologia. 2008 Aug;51(8):1382-90. doi: 10.1007/s00125-008-1046-4. Epub 2008 Jun 5.">A26300</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25621" data-original-title="Thongtang N, Ai M, Otokozawa S, Himbergen TV, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ: Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. Am J Cardiol. 2011 Feb 1;107(3):387-92. doi: 10.1016/j.amjcard.2010.09.031.">A25621</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25509" data-original-title="Saito Y, Yamada N, Shirai K, Sasaki J, Ebihara Y, Yanase T, Fox JC: Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia. Atherosclerosis. 2007 Oct;194(2):505-11. Epub 2007 Jan 16.">A25509</a></li></ul></td></tr><tr><td><a href="/drugs/DB09070">Tibolone</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>HDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Tibolone <em>decreases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25364" data-original-title="Godsland IF: Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril. 2001 May;75(5):898-915.">A25364</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26301" data-original-title="Dansuk R, Unal O, Karageyim Y, Esim E, Turan C: Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women. Gynecol Endocrinol. 2004 May;18(5):233-9.">A26301</a></li></ul></td></tr><tr><td><a href="/drugs/DB00227">Lovastatin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Lovastatin <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25397" data-original-title="Talpur R, Ward S, Apisarnthanarax N, Breuer-Mcham J, Duvic M: Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2002 Nov;47(5):672-84.">A25397</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26206" data-original-title="Yeshurun D, Abukarshin R, Elias N, Lanir A, Naschitz JE: Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination. Clin Ther. 1993 Mar-Apr;15(2):355-63.">A26206</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25182" data-original-title="Hidalgo L, Zambrana JL, Blanco-Molina A, Lopez-Granados A, Concha M, Casares J, Jimenez-Perez J, Lopez-Miranda J, Perez-Jimenez F: Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation. J Heart Lung Transplant. 1995 May-Jun;14(3):461-7.">A25182</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26129" data-original-title="Lea AP, McTavish D: Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997 May;53(5):828-47.">A26129</a></li></ul></td></tr><tr><td><a href="/drugs/DB09389">Norgestrel</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Norgestrel <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25097" data-original-title="Paterson ME, Sturdee DW, Moore B, Whitehead TP: The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women. Br J Obstet Gynaecol. 1980 Jul;87(7):552-60.">A25097</a></li></ul></td></tr><tr><td><a href="/drugs/DB00285">Venlafaxine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00259">Serotonin</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Venlafaxine <em>decreases</em> the level of <em>Serotonin</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26111" data-original-title="Blier P, Saint-Andre E, Hebert C, de Montigny C, Lavoie N, Debonnel G: Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Int J Neuropsychopharmacol. 2007 Feb;10(1):41-50. Epub 2006 May 11.">A26111</a></li></ul></td></tr><tr><td><a href="/drugs/DB00590">Doxazosin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>HDL cholesterol</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Doxazosin <em>increases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26302" data-original-title="Talseth T, Westlie L, Daae L: Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up. Am Heart J. 1991 Jan;121(1 Pt 2):280-5.">A26302</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24982" data-original-title="Grimm RH Jr: alpha 1-antagonists in the treatment of hypertension. Hypertension. 1989 May;13(5 Suppl):I131-6.">A24982</a></li></ul></td></tr><tr><td><a href="/drugs/DB01044">Gatifloxacin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00122">Glucose</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Gatifloxacin <em>decreases</em> the level of <em>Glucose</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26303" data-original-title="Gajjar DA, LaCreta FP, Uderman HD, Kollia GD, Duncan G, Birkhofer MJ, Grasela DM: A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men. Pharmacotherapy. 2000 Jun;20(6 Pt 2):49S-58S.">A26303</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25476" data-original-title="Mohr JF, McKinnon PS, Peymann PJ, Kenton I, Septimus E, Okhuysen PC: A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy. 2005 Oct;25(10):1303-9.">A25476</a></li></ul></td></tr></tbody></table><div class="pagination-holder"><div class="page_info">Displaying entries <b>2826&nbsp;-&nbsp;2850</b> of <b>3084</b> in total</div><nav><ul class="pagination pagination-sm"><li class="page-item first"><a class="page-link" href="/pharmaco/metabolomics">«</a></li><li class="page-item previous"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=113">‹</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=110">110</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=111">111</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=112">112</a></li><li class="page-item"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=113">113</a></li><li class="page-item active"><a remote="false" class="page-link">114</a></li><li class="page-item"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=115">115</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=116">116</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=117">117</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=118">118</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item next"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=115">›</a></li><li class="page-item last"><a class="page-link" href="/pharmaco/metabolomics?page=124">»</a></li></ul></nav></div></div></form></div></main><footer><div class="row p-3 p-sm-4 m-0"><div class="col-md-5 footer-content"><div class="footer-item footer-commercial"><img style="width: 130px; height: 100px;" src="/assets/plus/Data_Pink-68da9b7525141f098e2e0ebcbd888ce950fe6032fd0da3a227c22117cedd7062.png" alt="Data pink"><h2>Interested in using DrugBank in a <strong>commercial product</strong> or <strong>application?</strong></h2><a class="btn btn-pink-filled" target="_blank" href="https://www.drugbank.com/">Visit DrugBank.com <div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#see_more"> </use></svg></div></a></div><div class="footer-item footer-newsletter hidden" id="newsletter-1"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png" alt="Article dark pink"><h2>Stay up-to-date with the <br><strong>latest from DrugBank!</strong></h2></div><form action="https://dev.drugbank.com/contacts" class="form" id="newsletter-form" method="post"><input class="form-control hidden" id="contact_name" name="contact[name]" type="hidden" value="New Subscriber"><input class="form-control hidden" id="contact_mailing_list" name="contact[mailing_list]" type="hidden" value="yes"><input class="form-control hidden" id="data_type" name="data_type" type="hidden" value="json"><input class="form-control hidden" id="contact_address" name="contact[address]" type="hidden"><input class="form-control hidden" name="contact[return_url]" type="hidden" value="https://go.drugbank.com/#newsletter-3"><input class="form-control hidden" name="contact[form_url]" type="hidden" value="https://go.drugbank.com/"><input class="form-control hidden" id="referer" name="contact[referer]" type="hidden" value=""><input class="form-control hidden" id="type" name="contact[type]" type="hidden" value="newsletter"><input class="form-control hidden" id="ga_client_id" name="contact[ga_client_id]" type="hidden" value="1407225613.1636197853"><div class="input-group"><input class="form-control" id="contact_email" name="contact[email]" placeholder="Enter your email" required="" type="text"><span class="input-group-btn"><button class="btn btn-pink-filled" id="subscribe" type="submit">Subscribe</button></span></div><div class="help-block with-errors"></div></form></div><div class="footer-item footer-newsletter hidden" id="newsletter-3"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png" alt="Article dark pink"><h2><strong>Thank you</strong> <br>for subscribing!</h2></div></div></div><div class="col-md-7 footer-links"><div class="container"><div class="row footer-row"><div class="col-sm-4 footer-col"><div class="footer-header">About</div><div class="footer-list"><ul class="list-unstyled"><li><a href="/about">About DrugBank Online</a></li><li><a target="_blank" href="https://blog.drugbank.com/">Blog</a></li><li><a target="_blank" href="http://www.wishartlab.com">Wishart Research Group</a></li><li><a href="https://www.drugbank.com/about/careers">Careers</a></li><li><a href="/legal/terms_of_use">Terms of Use</a></li><li><a href="/legal/privacy_policy">Privacy Policy</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header">Support</div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://dev.drugbank.com/guides/index">Help Center</a></li><li><a target="_blank" href="https://dev.drugbank.com/guides/faqs">DrugBank Online FAQs</a></li><li><a href="/contact">Contact Support</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header"><a href="https://www.drugbank.com/">Commercial Data</a></div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://www.drugbank.com/clinical">Clinical Drug Data</a></li><li><a target="_blank" href="https://www.drugbank.com/scientific">Scientific Drug Data</a></li><li><a target="_blank" href="https://www.drugbank.com/contact/sales?ref=go.drugbank.com%2Fpharmaco%2Fmetabolomics">Contact Sales</a></li></ul></div></div></div><div class="row footer-row"><div class="col-sm-12"><div class="social-media"><a class="social-media-link" href="https://www.linkedin.com/company/drugbank/"><div class="drugbank-icon icon-linkedin"><svg class="icon" role="img" title="linkedin">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#linkedin"></use>
</svg>
</div></a><a class="social-media-link" href="https://twitter.com/DrugBankDB"><div class="drugbank-icon icon-twitter"><svg class="icon" role="img" title="twitter">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#twitter"></use>
</svg>
</div></a><a class="social-media-link" href="https://www.facebook.com/DrugBankDatabase"><div class="drugbank-icon icon-facebook"><svg class="icon" role="img" title="facebook">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#facebook"></use>
</svg>
</div></a></div><h6>Website design by Educe Design &amp; Innovation Inc.</h6></div></div></div></div></div></footer><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon="{&quot;rayId&quot;:&quot;6a9e139e0c5eacca&quot;,&quot;token&quot;:&quot;e28ec36f07f74c1ca13c169ca4430981&quot;,&quot;version&quot;:&quot;2021.10.0&quot;,&quot;si&quot;:100}"></script>
<script src="/assets/analytics-1b5960c76af2e5f1a83c45e21ee367baf13121e0a2d42380a71abadf0edaa402.js" media="all" data-turbolinks-track="true"></script><script type="text/javascript" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/2224137.js"></script></body></html>